These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital. Suwannalai P, Auethavekiat P, Udomsubpayakul U, Janvitayanujit S. Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328 [Abstract] [Full Text] [Related]
3. Infliximab to etanercept switch in patients with spondyloarthropathies and psoriatic arthritis: preliminary data. Delaunay C, Farrenq V, Marini-Portugal A, Cohen JD, Chevalier X, Claudepierre P. J Rheumatol; 2005 Nov; 32(11):2183-5. PubMed ID: 16265699 [Abstract] [Full Text] [Related]
5. Intra-articular infliximab in patients with rheumatoid arthritis and psoriatic arthritis with monoarthritis resistant to local glucocorticoids. Clinical efficacy extended to patients on systemic anti-tumour necrosis factor alpha. Conti F, Ceccarelli F, Priori R, Iagnocco A, Signore A, Valesini G. Ann Rheum Dis; 2008 Dec; 67(12):1787-90. PubMed ID: 19005158 [No Abstract] [Full Text] [Related]
12. Osteomyelitis occurring during infliximab treatment of severe psoriasis. Sri JC, Tsai CL, Deng A, Gaspari AA. J Drugs Dermatol; 2007 Feb 15; 6(2):207-10. PubMed ID: 17373180 [Abstract] [Full Text] [Related]